Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 5:15 pm Purchase | 2025-01-30 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 103,951 4.990% | 103,951 (New Position) | Filing History |
| 2025-02-04 7:51 pm Sale | 2025-01-31 | 13G | Enveric Biosciences, Inc. ENVB | Orca Capital AG | 97,019 4.900% | -69,648 (-41.79%) | Filing History |
| 2025-02-04 7:47 pm Purchase | 2025-01-30 | 13G | Enveric Biosciences, Inc. ENVB | Orca Capital AG | 166,667 8.700% | 166,667 (New Position) | Filing History |
| 2025-01-06 5:04 pm Purchase | 2024-12-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 39,990 5.900% | 15,520 (+63.43%) | Filing History |
| 2024-11-14 4:03 pm Sale | 2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB | Armistice Capital, LLC | 0 0.000% | -18,207 (Position Closed) | Filing History |
| 2024-11-13 11:18 am Purchase | 2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 19,333 3.100% | 9,667 (+100.00%) | Filing History |
| 2024-11-12 1:43 pm Purchase | 2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 24,470 4.110% | 16,717 (+215.62%) | Filing History |
| 2024-02-14 3:36 pm Purchase | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Armistice Capital, LLC | 18,207 9.990% | 18,207 (New Position) | Filing History |
| 2024-02-06 10:17 am Sale | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 9,667 6.200% | -4,076 (-29.66%) | Filing History |
| 2024-02-05 5:09 pm Unchanged | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Hudson Bay Capital Management LP | 7,357 4.540% | 0 (Unchanged) | Filing History |
| 2023-02-14 5:02 pm Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 7,753 5.600% | 7,753 (New Position) | Filing History |
| 2023-02-08 06:06 am Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 13,742 9.400% | 13,742 (New Position) | Filing History |
| 2023-02-07 4:28 pm Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Hudson Bay Capital Management LP | 7,357 5.040% | 7,357 (New Position) | Filing History |
| 2023-02-06 3:02 pm Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Alpha Capital Anstalt | 3,135 2.262% | 3,135 (New Position) | Filing History |
| 2022-08-01 06:10 am Purchase | 2022-07-22 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 8,656 9.990% | 8,656 (New Position) | Filing History |
| 2022-01-18 4:54 pm Purchase | 2021-12-31 | 13G | AMERI HLDGS INC AMRH | Alpha Capital Anstalt | 2,317,163 7.383% | 1,995,740 (+620.91%) | Filing History |
| 2021-02-10 12:29 pm Purchase | 2020-12-30 | 13G | Enveric Biosciences, Inc. ENVB | TOP Invest LLC | 3,065 19.800% | 3,065 (New Position) | Filing History |
| 2021-02-09 6:03 pm Unchanged | 2020-12-30 | 13G | Enveric Biosciences, Inc. ENVB | STEFANSKY DAVID | 1,531 9.990% | 0 (Unchanged) | Filing History |
| 2021-01-19 5:16 pm Purchase | 2020-12-30 | 13G | Enveric Biosciences, Inc. ENVB | STEFANSKY DAVID | 1,531 9.990% | 1,531 (New Position) | Filing History |
| 2021-01-12 4:42 pm Purchase | 2020-12-30 | 13G | Enveric Biosciences, Inc. ENVB | Chex Associates LLC | 1,177 7.620% | 1,177 (New Position) | Filing History |